X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/biovaxys-appoints-christopher-cherry-as-chief-financial-officer-302131360.html
https://www.prnewswire.com/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108919.html
https://www.prnewswire.com/news-releases/biovaxys-announces-allowance-of-dpx-formulation-patent-for-the-united-states-and-filing-of-additional-international-patent-applications-for-phase-1-dpx-surmage-302107159.html
https://www.prnewswire.com/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302083463.html
https://www.prnewswire.com/news-releases/biovaxys-announces-allowance-of-dpx-related-patent-for-japan-and-filing-of-additional-international-patent-applications-302079691.html
https://www.prnewswire.com/news-releases/biovaxys-acquires-all-intellectual-property-immunotherapeutics-platform-technology-and-clinical-stage-assets-of-the-former-imv-inc-302059809.html
https://www.indianpharmapost.com/news/biovaxys-executes-loi-for-major-immunotherapeutics-technology-acquisition-15066
https://www.prnewswire.com/news-releases/biovaxys-executes-letter-of-intent-for-major-immunotherapeutics-technology-acquisition-302021828.html
https://www.prnewswire.com/news-releases/biovaxys-in-non-binding-discussions-for-major-immunotherapeutics-technology-acquisition-302013317.html
https://www.prnewswire.com/news-releases/biovaxys-announces-sale-of-taet-software-co-301850191.html
Market Place
Share 
